![Hans Liljenborg](https://cdn.zonebourse.com/static/resize/768/576//static/images/insiders/unknown.png)
Hans Liljenborg
Corporate Officer/Principal at IMMUNOVIA AB
Network origin in Hans Liljenborg first degree
Entity | Entity type | Industry | |
---|---|---|---|
35
| Public Company | Pharmaceuticals: Major | 35 |
Gantus Training AB
1
| Private Company | 1 | |
Entreprenörskompetens i Lund AB
![]() Entreprenörskompetens i Lund AB Miscellaneous Commercial ServicesCommercial Services Entreprenörskompetens i Lund AB provides consulting services within business and organization development, entrepreneurship, and administration. The company was founded in 2005 and is headquartered in Lund, Sweden.
1
| Private Company | Miscellaneous Commercial Services | 1 |
Chart of Companies connected to the second degree
Multi-company connection
Companies connected to Hans Liljenborg via their personal network
Company | Sector | Related people | Main position |
---|---|---|---|
University of Lund | College/University | Doctorate Degree Undergraduate Degree Doctorate Degree Graduate Degree Graduate Degree Doctorate Degree Graduate Degree Undergraduate Degree | |
ALLIGATOR BIOSCIENCE AB | Biotechnology | Founder Director/Board Member Corporate Officer/Principal Chairman Investor Relations Contact | |
Dako ApS
![]() Dako ApS Electronic Equipment/InstrumentsElectronic Technology Part of Agilent Technologies, Inc., Dako ApS is a Danish company that designs and manufactures cancer diagnostic systems. The company is based in Glostrup, Denmark. | Electronic Equipment/Instruments | Corporate Officer/Principal Corporate Officer/Principal Sales & Marketing | |
Dako Denmark ApS
![]() Dako Denmark ApS Medical SpecialtiesHealth Technology Dako Denmark A/S designs and manufactures cancer diagnostic systems. It produces reagents, antibodies, instruments, and software solutions to make diagnoses and determine treatments for patients suffering from cancer. The firm's product areas encompass Immunohistochemistry, pharmacoDiagnostics, molecular pathology, Hematoxylin and Eosin stain, special stains, flow Cytometry, and specific proteins. The company was founded by Niels Harboe in 1966 and is headquartered in Glostrup, Denmark. | Medical Specialties | Chief Executive Officer Chief Tech/Sci/R&D Officer Sales & Marketing | |
SCANDION ONCOLOGY A/S | Pharmaceuticals: Major | Director/Board Member Chairman Chairman | |
Euro-Diagnostica AB
![]() Euro-Diagnostica AB Pharmaceuticals: MajorHealth Technology Euro-Diagnostica AB provides autoimmunity testing and diagnostic solutions. It facilitates the development of safe and efficient drugs and optimal treatment of patients by providing cutting edge assays. The firm also provides clinical labs and physicians with tools to aid in diagnosis, prognosis, monitoring, and treatment of inflammatory and related diseases. The company was founded in 1992 and is headquartered in Malmo, Sweden. | Pharmaceuticals: Major | General Counsel Sales & Marketing Corporate Officer/Principal | |
SENZAGEN AB | Biotechnology | Founder Director/Board Member Director/Board Member | |
University of Copenhagen | College/University | Doctorate Degree Graduate Degree Graduate Degree | |
Edvince AB
![]() Edvince AB BiotechnologyHealth Technology Edvince AB engages in clinical research and development services. It operates as a biotech company that focuses on a new form of emergency treatment for stroke. The company was founded by Lars Ingvar Herbert Edvinsson in 2003 and is headquartered in Lund, Sweden. | Biotechnology | Chairman Director/Board Member | |
BIOINVENT INTERNATIONAL AB | Biotechnology | Founder Director/Board Member | |
QIAGEN N.V. | Medical Specialties | General Counsel Compliance Officer | |
Gradientech AB
![]() Gradientech AB BiotechnologyHealth Technology Gradientech AB operates as biotech and diagnostics company. It develops and provides ultra-rapid antibiotic susceptibility testing products. The company's products include QuickMic, CellDirector and Tracking Tool PRO. Gradientech was founded by Sara Ulrika Thorslund and Johan Kreuger in 2009 and is headquartered in Uppsala, Sweden. | Biotechnology | Director/Board Member Director/Board Member | |
Åbo Akademi University | College/University | Graduate Degree Graduate Degree | |
Amersham Biosciences AB | Corporate Officer/Principal Sales & Marketing | ||
Wallac Oy | Corporate Officer/Principal Corporate Officer/Principal | ||
BIOTAGE AB | Medical Specialties | Director/Board Member Chief Executive Officer | |
GE Healthcare AB
![]() GE Healthcare AB Pharmaceuticals: MajorHealth Technology GE Healthcare AB wholesales and distributes pharmaceutical products. It promotes contrast agents for X-rays, magnetic resonance imaging, ultrasound and radiopharmaceuticals, use to predict and diagnose early-stage diseases. The company was founded on October 21, 1983 and is headquartered in Danderyd, Sweden. | Pharmaceuticals: Major | Corporate Officer/Principal Sales & Marketing | |
REVVITY, INC. | Medical Specialties | Corporate Officer/Principal Corporate Officer/Principal | |
ELEKTA AB | Medical Specialties | Director/Board Member Public Communications Contact | |
Atlas Therapeutics AB
![]() Atlas Therapeutics AB Pharmaceuticals: MajorHealth Technology Part of Alligator Bioscience AB, Atlas Therapeutics AB develops and manufactures antibody drugs. The company is based in Stockholm, Sweden. Atlas Therapeutics was acquired by Alligator Bioscience AB on October 18, 2013. | Pharmaceuticals: Major | Director/Board Member Chairman | |
Immunovia, Inc. | Chief Tech/Sci/R&D Officer Chief Executive Officer | ||
Cellevate AB
![]() Cellevate AB Miscellaneous Commercial ServicesCommercial Services Cellevate AB is a Swedish biotech company that specializes in developing advanced cell culture systems. The private company is based in Lund, Sweden. The company's patented manufacturing process creates highly porous and consistent networks of nanofibers. Cellevate was founded by Lars Gosta Montelius. | Miscellaneous Commercial Services | Director/Board Member Chief Executive Officer | |
AROCELL AB | Medical Specialties | Chairman | |
Phadia AB
![]() Phadia AB Medical SpecialtiesHealth Technology Phadia AB develops, manufactures and markets blood test systems to support the clinical diagnosis and monitoring of allergy, asthma and autoimmune diseases. The company was founded in 2004 and is headquartered in Uppdala, Sweden. | Medical Specialties | Corporate Officer/Principal | |
Thermofisher, Inc.
![]() Thermofisher, Inc. Chemicals: SpecialtyProcess Industries Thermofisher, Inc. manufactures polymers. The private company is based in Vännäs, Sweden. | Chemicals: Specialty | Corporate Officer/Principal | |
Duvbo Affarskonsult AB
![]() Duvbo Affarskonsult AB Real Estate DevelopmentFinance Duvbo Affarskonsult AB provides real estate services. The private company is based in Stockholm, Sweden. | Real Estate Development | Corporate Officer/Principal | |
Prexton Therapeutics SA
![]() Prexton Therapeutics SA Pharmaceuticals: MajorHealth Technology Prexton Therapeutics SA operates as a biopharmaceutical company which develops novel therapeutic compounds as a new treatment for Parkinson’s disease and other brain disorders. The company was founded by Francois Conquet in 2012 and is headquartered in Geneva, Switzerland. | Pharmaceuticals: Major | Founder | |
Uppsala Innovation Centre AB
![]() Uppsala Innovation Centre AB Miscellaneous Commercial ServicesCommercial Services Uppsala Innovation Centre AB provides professional training services. The private company is based in Uppsala, Sweden. | Miscellaneous Commercial Services | Director/Board Member | |
Single Technologies AB
![]() Single Technologies AB Miscellaneous Commercial ServicesCommercial Services Single Technologies AB develops 3-D sequencing technology. The company is based in Stockholm, Sweden. The Swedish company was founded in 2014 by Johan Strömqvist, Annika Bolind Bågenholm, Bengt Sahlgren, Raoul Stubbe. | Miscellaneous Commercial Services | Director/Board Member | |
Affibody AB
![]() Affibody AB Miscellaneous Commercial ServicesCommercial Services Affibody AB conducts research and development services within biotechnology. It markets and sells licensed products and research findings to the pharmaceutical industry. The company was founded by Karin Nord in 1998 and is headquartered in Stockholm, Sweden. | Miscellaneous Commercial Services | Director/Board Member | |
SWElife
![]() SWElife Miscellaneous Commercial ServicesCommercial Services SWElife engages in the development, utilization, and evaluation of innovations in healthcare. The private company is based in Lund, Sweden. | Miscellaneous Commercial Services | Director/Board Member | |
Doloradix AB
![]() Doloradix AB Miscellaneous Commercial ServicesCommercial Services Doloradix AB is a Swedish biotechnology company that focuses on research and development. The private company is based in Uppsala, Sweden. | Miscellaneous Commercial Services | Chairman | |
Myrtila AB
![]() Myrtila AB Miscellaneous Commercial ServicesCommercial Services Myrtila AB provides business consulting services. The private company is based in Uppsala, Sweden. | Miscellaneous Commercial Services | Chairman | |
Q-LINEA AB | Medical Specialties | Director/Board Member | |
Duvbo Projektkonsult AB | Corporate Officer/Principal | ||
Lundbeck Pharma A/S
![]() Lundbeck Pharma A/S Medical DistributorsDistribution Services Lundbeck Pharma A/S markets and sells medicines within Central Nervous System. It specializes in various illnesses and conditions such as depression, Schizophrenia, anxiety, alcohol dependence, and Parkinson's and Alzheimer's diseases. The company was founded on January 1, 1988 and is headquartered in Valby, Denmark. | Medical Distributors | General Counsel | |
H. LUNDBECK A/S | Pharmaceuticals: Major | Chief Tech/Sci/R&D Officer | |
Scandinavian Society for Psychopharmacology | Corporate Officer/Principal | ||
European Federation of Pharmaceutical Industries & Assns
![]() European Federation of Pharmaceutical Industries & Assns Miscellaneous Commercial ServicesCommercial Services The European Federation of Pharmaceutical Industries & Assns is a trade association that promotes pharmaceutical discovery and development. The non-profit company is based in Brussels, Belgium. | Miscellaneous Commercial Services | Chief Tech/Sci/R&D Officer | |
Collegium Internationale Neuro-Psychopharmacologicum | Corporate Officer/Principal | ||
Lundbeck Research USA, Inc.
![]() Lundbeck Research USA, Inc. Pharmaceuticals: MajorHealth Technology Lundbeck Research USA, Inc. develops pharmaceutical products and information to the medical community. The firm engages in the drug discovery aimed at treating central nervous system diseases by designing small molecule therapeutics. The company was founded in 1990 and is headquartered in Paramus, NJ. | Pharmaceuticals: Major | Chairman | |
NOVO NORDISK A/S | Pharmaceuticals: Major | Corporate Officer/Principal | |
Ossianix, Inc.
![]() Ossianix, Inc. Pharmaceuticals: GenericHealth Technology Ossianix, Inc. develops single domain antibodies. It develops biotherapeutic products using the versatile single domain VNAR antibody from the shark and also developed highly innovative approaches to target specific cells and tissues such as the brain via the blood brain barrier and peripheral nerve via the neuromuscular junction. The company was founded by Frank S. Walshin, J. Lynn Rutkowski and Corey S. Goodman in 2011 and is headquartered in Philadelphia, PA. | Pharmaceuticals: Generic | Director/Board Member | |
ACADIA Pharmaceuticals A/S
![]() ACADIA Pharmaceuticals A/S Miscellaneous Commercial ServicesCommercial Services Part of ACADIA Pharmaceuticals, Inc., ACADIA Pharmaceuticals A/S utilizes technology to fuel drug discovery and clinical development. The company is based in Glostrup, Denmark. The Danish company was founded by Peter Høngaard Andersen. | Miscellaneous Commercial Services | Founder | |
EpiTherapeutics ApS
![]() EpiTherapeutics ApS BiotechnologyHealth Technology EpiTherapeutics ApS is a holding company that develops cancer drugs based on research in the field of epigenetics. Its development programs are focused on enzymes involved in the regulation of transcription in cancer - current programs target histone demethylases and methyltransferases. The firm's regulation is commonly used for post-translational covalent modifications of histones and other chromatin-remodeling complexes, which determines whether a gene is accessible and hence, expressed or repressed. Its covalent modifications involved in epigenetic regulation include deoxyribonucleic acid methylation, histone acetylation, and histone methylation. The company was founded by Kristian Helin, Paul Andreas Compare Cloos, Jesper Aagaard Christensen, Karl Agger, and Klaus Hansen on September 18, 2008 and is headquartered in Greve, Denmark. | Biotechnology | Founder | |
PerkinElmer Oy
![]() PerkinElmer Oy Medical SpecialtiesHealth Technology PerkinElmer Oy engages in the provision of products and solutions to diagnostics, research, and laboratory services. It specializes in environmental analysis, food and consumer product safety, medical imaging, drug discovery, diagnostics, biotechnology, industrial applications, and life science research. The company was founded on June 7, 1999 and is headquartered in Turku, Finland. | Medical Specialties | Corporate Officer/Principal |
Statistics
International
Sweden | 28 |
Denmark | 12 |
United States | 5 |
Finland | 4 |
Netherlands | 3 |
Sectoral
Health Technology | 28 |
Commercial Services | 10 |
Consumer Services | 4 |
Finance | 3 |
Electronic Technology | 2 |
Operational
Director/Board Member | 158 |
Corporate Officer/Principal | 75 |
Chairman | 52 |
Independent Dir/Board Member | 36 |
Chief Executive Officer | 32 |
Most connected contacts
- Stock Market
- Insiders
- Hans Liljenborg
- Company connections